| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/JAMA.2014.5988 |
| P698 | PubMed publication ID | 24915261 |
| P50 | author | Claude Bouchard | Q2977048 |
| Per-Arne Svensson | Q42440384 | ||
| Markku Peltonen | Q42883335 | ||
| Kajsa Sjöholm | Q43275758 | ||
| Peter Jacobson | Q54097442 | ||
| Johanna C Andersson-Assarsson | Q57295764 | ||
| Sofie Ahlin | Q57305096 | ||
| Magdalena Taube | Q87462610 | ||
| P2093 | author name string | Björn Carlsson | |
| Lena M S Carlsson | |||
| Ingmar Näslund | |||
| Lars Sjöström | |||
| Hans Wedel | |||
| Kristjan Karason | |||
| Hans Lönroth | |||
| Åsa Anveden | |||
| Elisabeth Sjöström | |||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type 2 diabetes | Q3025883 |
| microvessel | Q6840468 | ||
| bariatric surgery | Q357503 | ||
| P304 | page(s) | 2297-2304 | |
| P577 | publication date | 2014-06-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications | |
| P478 | volume | 311 |
| Q92807729 | 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea |
| Q36942815 | 4-Year Cost Trajectories in Real-World Patients Matched to the Metabolic Profiles of Trial Subjects Before/After Treatment with Phentermine-Topiramate. |
| Q48148015 | A Longitudinal Analysis of Short-Term Costs and Outcomes in a Regionalized Center of Excellence Bariatric Care System |
| Q90360193 | A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans |
| Q28080484 | A gut feeling to cure diabetes: potential mechanisms of diabetes remission after bariatric surgery |
| Q90629107 | A novel fast-slow model of diabetes progression: Insights into mechanisms of response to the interventions in the Diabetes Prevention Program |
| Q47903226 | A qualitative study of the role of Australian general practitioners in the surgical management of obesity |
| Q90221587 | Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease |
| Q38650931 | All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes. |
| Q36108731 | Alterations in gut microbiota during remission and recurrence of diabetes after duodenal-jejunal bypass in rats |
| Q60926597 | An 8-week diet high in cereal fiber and coffee but free of red meat does not improve beta-cell function in patients with type 2 diabetes mellitus: a randomized controlled trial |
| Q28388245 | An Untargeted Metabolomics Approach to Characterize Short-Term and Long-Term Metabolic Changes after Bariatric Surgery |
| Q37322475 | Application of side-to-side anastomosis of the lesser curvature of stomach and jejunum in gastric bypass |
| Q48148032 | Assessing the Actual Clinical Effectiveness of Metabolic/Bariatric Surgery for the Type 2 Diabetes Therapy. |
| Q27008820 | Assessing the obese diabetic patient for bariatric surgery: which candidate do I choose? |
| Q57458741 | Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity |
| Q93049476 | Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity |
| Q57136935 | Association of circulating proinflammatory marker, leucine-rich-α2-glycoprotein (LRG1), following metabolic/bariatric surgery |
| Q38258985 | Association of race and socioeconomic status with outcomes following laparoscopic Roux-en-Y gastric bypass |
| Q59499159 | Associations of dietitian follow-up counselling visits and physical exercise with weight loss one year after sleeve gastrectomy |
| Q87318377 | Balancing risks and benefits of bariatric surgery for type 2 diabetes |
| Q36005792 | Bariatric Surgery Restores Cardiac and Sudomotor Autonomic C-Fiber Dysfunction towards Normal in Obese Subjects with Type 2 Diabetes. |
| Q47628225 | Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study |
| Q38960171 | Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes |
| Q38572077 | Bariatric Surgery versus Intensive Medical Weight Management for Type 2 Diabetes. |
| Q37652822 | Bariatric Surgery: A Potential Treatment for Type 2 Diabetes in Youth |
| Q30377144 | Bariatric and Metabolic Surgery in Adolescents: a Path to Decrease Adult Cardiovascular Mortality. |
| Q38410200 | Bariatric and metabolic surgery: a shift in eligibility and success criteria |
| Q39085972 | Bariatric surgery and diabetic retinopathy: a systematic review and meta-analysis of controlled clinical studies |
| Q33838154 | Bariatric surgery and obesity: influence on the incretins |
| Q91069213 | Bariatric surgery and type 2 diabetes: a step closer to defining an optimal approach |
| Q36163431 | Bariatric surgery and type 2 diabetes: are there weight loss-independent therapeutic effects of upper gastrointestinal bypass? |
| Q88832450 | Bariatric surgery for nonalcoholic steatohepatitis: A clinical and cost-effectiveness analysis |
| Q98303354 | Bariatric surgery for the treatment of chronic kidney disease in obesity and type 2 diabetes mellitus |
| Q37017318 | Bariatric surgery is associated with improvement in kidney outcomes. |
| Q50083483 | Bariatric surgery reduces fasting total fatty acids and increases n-3 polyunsaturated fatty acids in morbidly obese individuals |
| Q35564937 | Bariatric surgery: prevalence, predictors, and mechanisms of diabetes remission |
| Q53344977 | Bariatric surgery: time to move beyond clinical outcomes. |
| Q47965626 | Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial |
| Q36930271 | Bariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients With a BMI <35 kg/m2 |
| Q38581330 | Behavioural Interventions for Severe Obesity Before and/or After Bariatric Surgery: a Systematic Review and Meta-analysis |
| Q92875316 | Bile acid changes after metabolic surgery are linked to improvement in insulin sensitivity |
| Q36820583 | Brain and White Matter Hyperintensity Volumes After 10 Years of Random Assignment to Lifestyle Intervention |
| Q64237221 | Calorie restriction for long-term remission of type 2 diabetes |
| Q35592620 | Cardiovascular and renal effects of weight reduction in obesity and the metabolic syndrome |
| Q39106973 | Cardiovascular consequences of metabolic syndrome. |
| Q38985963 | Cardiovascular effects of bariatric surgery |
| Q92068528 | Cardiovascular risk reduction following metabolic and bariatric surgery |
| Q38430788 | Cardiovascular, renal and overall health outcomes after bariatric surgery. |
| Q50430964 | Changes in adiposity and other cardiometabolic risk factors following Roux-en-Y gastric bypass: A 12-month prospective cohort study in Chinese patients |
| Q37110266 | Changing Epidemiology of Bariatric Surgery in the UK: Cohort Study Using Primary Care Electronic Health Records. |
| Q38572961 | Clinical Management of Type 2 Diabetes Mellitus after Bariatric Surgery |
| Q39737868 | Clinical Outcomes of Metabolic Surgery: Efficacy of Glycemic Control, Weight Loss, and Remission of Diabetes |
| Q38843881 | Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications |
| Q45067579 | Clinical significance of failure to lose weight 10 years after roux-en-y gastric bypass |
| Q92178332 | Clusters of Glycemic Response to Oral Glucose Tolerance Tests Explain Multivariate Metabolic and Anthropometric Outcomes of Bariatric Surgery in Obese Patients |
| Q93379569 | Comorbidities as an Indication for Metabolic Surgery |
| Q88034892 | Comparison of Surgical and Medical Therapy for Type 2 Diabetes in Severely Obese Adolescents |
| Q26779285 | Control of Body Weight by Eating Behavior in Children |
| Q38358945 | Controversies in bariatric surgery |
| Q64248633 | Cost-Effectiveness Evaluation of Bariatric Surgery for Morbidly Obese with Diabetes Patients in Thailand |
| Q41136739 | Cost-effectiveness of gastric band surgery for overweight but not obese adults with type 2 diabetes in the U.S. |
| Q59336864 | Current and future impact of clinical gastrointestinal research on patient care in diabetes mellitus |
| Q49540088 | Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery |
| Q51245636 | Development of De Novo Diabetes in Long-Term Follow-up After Bariatric Surgery. |
| Q47184138 | Diabetes Outcomes More than a Decade Following Sustained Weight Loss After Laparoscopic Adjustable Gastric Band Surgery |
| Q38812184 | Diabetes after Bariatric Surgery |
| Q56977501 | Diabetes remission and relapse after metabolic surgery |
| Q41467110 | Diabetes-associated microbiota in fa/fa rats is modified by Roux-en-Y gastric bypass |
| Q97636305 | Diet and exercise in the prevention and treatment of type 2 diabetes mellitus |
| Q47389392 | Dietary and psych predictors of weight loss after gastric bypass. |
| Q47765493 | Does Post-operative Psychotherapy Contribute to Improved Comorbidities in Bariatric Patients with Borderline Personality Disorder Traits and Bulimia Tendencies? A Prospective Study |
| Q88747509 | Downregulation of lncRNA MALAT1 contributes to renal functional improvement after duodenal-jejunal bypass in a diabetic rat model |
| Q57104599 | Duodenal-Jejunal Bypass Preferentially Elevates Serum Taurine-Conjugated Bile Acids and Alters Gut Microbiota in a Diabetic Rat Model |
| Q40696946 | Durability of Addition of Roux-en-Y Gastric Bypass to Lifestyle Intervention and Medical Management in Achieving Primary Treatment Goals for Uncontrolled Type 2 Diabetes in Mild to Moderate Obesity: A Randomized Control Trial |
| Q92245135 | Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial |
| Q90043366 | Effect of Bariatric Surgery on Diagnosed Chronic Kidney Disease and Cardiovascular Events in Patients with Insulin-treated Type 2 Diabetes: a Retrospective Cohort Study from a Large UK Primary Care Database |
| Q37245909 | Effect of Contemporary Bariatric Surgical Procedures on Type 2 Diabetes Remission. A Population-Based Matched Cohort Study |
| Q47547235 | Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial |
| Q92202538 | Effect of Roux-en-Y gastric bypass on pharmacologic dependence in obese patients with type 2 diabetes |
| Q63727426 | Effect of Roux-en-Y gastric bypass surgery on diabetes remission and complications in individuals with type 2 diabetes: a Danish population-based matched cohort study |
| Q51299591 | Effect of Sleeve Gastrectomy Plus Side-to-Side Jejunoileal Anastomosis for Type 2 Diabetes Control in an Obese Rat Model. |
| Q95643631 | Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial |
| Q57188823 | Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial |
| Q38625348 | Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis |
| Q88477566 | Effects of Different Weight Loss Approaches on CVD Risk |
| Q47112764 | Effects of Laparoscopic Roux-en-Y Gastric Bypass for Type 2 Diabetes Mellitus: Comparison of BMI > 30 and < 30 kg/m2. |
| Q30983590 | Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies |
| Q39251105 | Elective surgery to save my life: rethinking the "choice" in bariatric surgery. |
| Q64286442 | Endocrine implications of bariatric surgery: a review on the intersection between incretins, bone, and sex hormones |
| Q38817948 | Endoscopic Devices for Obesity |
| Q38269818 | Ethical issues in the psychosocial assessment of bariatric surgery candidates |
| Q47245568 | Ethnicity Does Not Influence Glycemic Outcomes or Diabetes Remission After Sleeve Gastrectomy or Gastric Bypass in a Multiethnic Asian Cohort. |
| Q57687713 | European Obesity Summit (EOS) - Joint Congress of EASOand IFSO-EC, Gothenburg, Sweden, June 1 - 4, 2016: Abstracts |
| Q90177543 | Exercise and apulian hypocaloric diet affect adipokine changes and gastric banding-induced weight loss: A prospective study on severe obese subjects |
| Q40034159 | Experiences of accessing obesity surgery on the NHS: a qualitative study |
| Q36120645 | Extensive weight loss reveals distinct gene expression changes in human subcutaneous and visceral adipose tissue |
| Q92486848 | Five-year effectiveness of bariatric surgery on disease remission, weight loss, and changes of metabolic parameters in obese patients with type 2 diabetes: A population-based propensity score-matched cohort study |
| Q26769996 | From bariatric to metabolic surgery: Looking for a "disease modifier" surgery for type 2 diabetes |
| Q42477270 | Gastric Band Surgery Leads to Improved Insulin Secretion in Overweight People with Type 2 Diabetes |
| Q52916575 | Gastric Bypass-Related Effects on Glucose Control, β Cell Function and Morphology in the Obese Zucker Rat. |
| Q50249551 | Gastric bypass surgery does not increase the risk for sight-threatening diabetic retinopathy |
| Q35994552 | Gastrointestinal traits: individualizing therapy for obesity with drugs and devices |
| Q40258640 | Geographic and socioeconomic factors affecting delivery of bariatric surgery across high- and low-utilization healthcare systems. |
| Q92882032 | Gut Microbiota Profile of Obese Diabetic Women Submitted to Roux-en-Y Gastric Bypass and Its Association with Food Intake and Postoperative Diabetes Remission |
| Q36936333 | Health-care costs over 15 years after bariatric surgery for patients with different baseline glucose status: results from the Swedish Obese Subjects study. |
| Q30238784 | Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association |
| Q47650828 | Higher plasma motilin levels in obese patients decrease after Roux-en-Y gastric bypass surgery and regulate hunger. |
| Q34009868 | Homeostasis in anorexia nervosa |
| Q38559029 | How Durable Are the Effects After Metabolic Surgery? |
| Q36299055 | Impact of Bariatric Surgery on Metabolic and Gut Microbiota Profile: a Systematic Review and Meta-analysis. |
| Q36326901 | Impact of Bariatric Surgery on Patients With Rheumatoid Arthritis |
| Q41043481 | Impact of sleeve gastrectomy verses sleeve gastrectomy plus side-to-side jejunoileal anastomosis on weight loss and metabolic control in an obese rat model. |
| Q47390388 | Incidence and remission of type 2 diabetes in relation to degree of obesity at baseline and 2 year weight change: the Swedish Obese Subjects (SOS) study. |
| Q50605542 | Incidence of type 2 diabetes after bariatric surgery: population-based matched cohort study. |
| Q48105334 | Inflammatory markers, the tryptophan-kynurenine pathway, and vitamin B status after bariatric surgery |
| Q92511565 | Influence of glucometric 'dynamical' variables on duodenal-jejunal bypass liner (DJBL) anthropometric and metabolic outcomes |
| Q94476043 | Is Roux-en-Y gastric bypass advantageous?-surgical outcomes in obese patients with type-2 diabetes after gastric bypass versus sleeve gastrectomy, a matched retrospective study |
| Q47591968 | Is there a Reason Why Obese Patients Choose Either Conservative Treatment or Surgery? |
| Q50014509 | Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study |
| Q38241747 | Lifestyle management for enhancing outcomes after bariatric surgery. |
| Q37639561 | Limitations of the DiaRem Score in Predicting Remission of Diabetes Following Roux-En-Y Gastric Bypass (RYGB) in an ethnically Diverse Population from a Single Institution in the UK. |
| Q92970677 | Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical Trial |
| Q47809289 | Long-Term Outcomes in Patients with Morbid Obesity and Type 1 Diabetes Undergoing Bariatric Surgery |
| Q54314693 | Long-Term Outcomes of Three Types of Bariatric Surgery on Obesity and Type 2 Diabetes Control and Remission. |
| Q41862134 | Long-term Microvascular Disease Outcomes in Patients With Type 2 Diabetes After Bariatric Surgery: Evidence for the Legacy Effect of Surgery. |
| Q64899535 | Long-term effect of bariatric surgery versus conventional therapy in obese Korean patients: a multicenter retrospective cohort study. |
| Q38753187 | Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study |
| Q91638592 | Long-term outcomes of macrovascular diseases and metabolic indicators of bariatric surgery for severe obesity type 2 diabetes patients with a meta-analysis |
| Q38880154 | Long-term pharmacotherapy considerations in the bariatric surgery patient |
| Q89677265 | Low-energy total diet replacement intervention in patients with type 2 diabetes mellitus and obesity treated with insulin: a randomized trial |
| Q40965539 | Macrovascular and microvascular disease in obese patients with type 2 diabetes attending structured diabetes education program: a population-based propensity-matched cohort analysis of Patient Empowerment Programme (PEP). |
| Q57026285 | Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) |
| Q56979722 | Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) |
| Q34513665 | Management of obesity |
| Q34898952 | Mechanisms underlying weight loss and metabolic improvements in rodent models of bariatric surgery |
| Q36132127 | Meta-analysis of bariatric surgery versus non-surgical treatment for type 2 diabetes mellitus |
| Q90704889 | Metabolic Surgery Comparing Sleeve Gastrectomy with Jejunal Bypass and Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients After 3 Years |
| Q36930263 | Metabolic Surgery for Type 2 Diabetes: Changing the Landscape of Diabetes Care |
| Q51841828 | Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: a Joint Statement by International Diabetes Organizations. |
| Q91904158 | Metabolic and bariatric surgery in adolescents |
| Q91445282 | Metabolic effects and safety of Roux-en-Y gastric bypass surgery vs. conventional medication in obese Chinese patients with type 2 diabetes |
| Q64279596 | MiR-802 causes nephropathy by suppressing NF-κB-repressing factor in obese mice and human |
| Q37598327 | Microvascular Outcomes after Metabolic Surgery (MOMS) in patients with type 2 diabetes mellitus and class I obesity: rationale and design for a randomised controlled trial |
| Q89365051 | Microvascular complications after metabolic surgery |
| Q89127179 | Mid-term 4-Year Outcomes with Single Anastomosis Duodenal-Ileal Bypass with Sleeve Gastrectomy Surgery at a Single US Center |
| Q48370723 | Non-alcoholic Fatty Liver Disease in Morbidly Obese Individuals Undergoing Bariatric Surgery: Prevalence and Effect of the Pre-Bariatric Very Low Calorie Diet. |
| Q57069665 | Non-insulin determinant pathways maintain glucose homeostasis upon metabolic surgery |
| Q40293179 | Not 'Taking the Easy Way Out': Reframing Bariatric Surgery from Low-effort Weight Loss to Hard Work |
| Q38259507 | Novel therapeutics for type 2 diabetes: insulin resistance |
| Q89996332 | Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report |
| Q88317935 | Obesity |
| Q36567721 | Obesity Education Strategies for Cancer Prevention in Women's Health |
| Q89796696 | Obesity, metabolic syndrome and bariatric surgery: A narrative review |
| Q34079744 | Omentin changes following bariatric surgery and predictive links with biomarkers for risk of cardiovascular disease |
| Q37429182 | Outcomes associated with preoperative weight loss after laparoscopic Roux-en-Y gastric bypass |
| Q49271393 | Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre. |
| Q58608335 | Outcomes of Bariatric Surgery Versus Medical Management for Type 2 Diabetes Mellitus: a Meta-Analysis of Randomized Controlled Trials |
| Q36383569 | Over-drainage and persistent shunt-dependency in patients with idiopathic intracranial hypertension treated with shunts and bariatric surgery |
| Q58608339 | Patients with Schizophrenia Do Not Demonstrate Worse Outcome After Sleeve Gastrectomy: a Short-Term Cohort Study |
| Q38965089 | Physiological and molecular responses to bariatric surgery: markers or mechanisms underlying T2DM resolution? |
| Q89582075 | Predicting 10-Year Risk of End-Organ Complications of Type 2 Diabetes With and Without Metabolic Surgery: A Machine Learning Approach |
| Q92025427 | Prediction of Type 2 Diabetes Remission after Bariatric or Metabolic Surgery |
| Q38645171 | Predictors of Long-Term Remission and Relapse of Type 2 Diabetes Mellitus Following Gastric Bypass in Severely Obese Patients |
| Q33849400 | Preserved Fat-Free Mass after Gastric Bypass and Duodenal Switch |
| Q40050350 | Prevalence and Trends in Lifetime Obesity in the U.S., 1988-2014. |
| Q47174377 | Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. |
| Q41418018 | Progression of diabetic retinopathy after bariatric surgery |
| Q61816585 | Pros and cons of gastric bypass surgery in individuals with obesity and type 2 diabetes: nationwide, matched, observational cohort study |
| Q50079410 | Prospective evaluation of insulin and incretin dynamics in obese adults with and without diabetes for 2 years after Roux-en-Y gastric bypass. |
| Q39099850 | Protocol for Standardizing High-to-Moderate Abundance Protein Biomarker Assessments Through an MRM-with-Standard-Peptides Quantitative Approach. |
| Q38585874 | Psychosocial Interventions Pre and Post Bariatric Surgery |
| Q36972583 | Quantitative high-throughput profiling of environmental chemicals and drugs that modulate farnesoid X receptor |
| Q36505804 | RYGB progressively increases avidity for a low-energy, artificially sweetened diet in female rats |
| Q47105166 | Ranking factors involved in diabetes remission after bariatric surgery using machine-learning integrating clinical and genomic biomarkers |
| Q53086906 | Rationale and design of the Early Sleeve gastrectomy In New Onset Diabetic Obese Patients (ESINODOP) trial. |
| Q55084988 | Recent advancements in bariatric/metabolic surgery. |
| Q38849378 | Recent advances in the modification of taste and food preferences following bariatric surgery. |
| Q47197138 | Relevance of weight in the management of patients with type 2 diabetes mellitus: towards an adipocentric approach to diabetes |
| Q101410033 | Remission and progression of pre-existing micro- and macroalbuminuria over 15 years after bariatric surgery in Swedish Obese Subjects study |
| Q93078585 | Remission of Type 2 Diabetes Mellitus after Bariatric Surgery: Fact or Fiction? |
| Q50182622 | Remission of hyperglycemia after withdrawal of oral antidiabetic drugs in Japanese patients with early stage of type 2 diabetes. |
| Q37595227 | Renal Function in Type 2 Diabetes Following Gastric Bypass |
| Q38235543 | Review article: The nutritional and pharmacological consequences of obesity surgery. |
| Q38843488 | Revisional Bariatric/Metabolic Surgery: What Dictates Its Indications? |
| Q48250560 | Risk Prediction Model for Severe Postoperative Complication in Bariatric Surgery |
| Q57808816 | Risk of Suicide and Self-harm Is Increased After Bariatric Surgery-a Systematic Review and Meta-analysis |
| Q47556387 | Risk of suicide and non-fatal self-harm after bariatric surgery: results from two matched cohort studies |
| Q42378271 | Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass |
| Q51245449 | Roux-en-Y Gastric Bypass Compared to Equivalent Diet Restriction: Mechanistic Insights into Diabetes Remission. |
| Q35577707 | Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission |
| Q37110207 | Roux-en-Y Gastric Bypass vs. Sleeve Gastrectomy vs. Gastric Banding: The First Multicenter Retrospective Comparative Cohort Study in Obese Korean Patients |
| Q30277200 | Roux-en-Y gastric bypass 10-year follow-up: the found population |
| Q35771371 | Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial |
| Q39910836 | Serum Leptin and Adiponectin Concentration in Type 2 Diabetes Patients in the Short and Long Term Following Biliopancreatic Diversion. |
| Q45539867 | Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study |
| Q92600689 | Standards of medical care for type 2 diabetes in China 2019 |
| Q33570308 | Surgical Treatment of Diabetes: Making a Case for a Pragmatic Approach |
| Q39030273 | Surgical Treatment of Metabolic Syndrome |
| Q58167169 | Surgical or medical therapy for patients with obesity and T2DM? |
| Q38690163 | Targeting the gut to treat obesity and its metabolic comorbidities: focus on bariatric surgery - view from the chair |
| Q28075888 | The Effect of Bariatric Surgery on Diabetic Retinopathy: Good, Bad, or Both? |
| Q92106421 | The Effect of Laparoscopic Gastric Bypass Surgery on Insulin Resistance and Glycosylated Hemoglobin A1c: a 2-Year Follow-up Study |
| Q64234849 | The Feasibility of Examining the Effects of Gastric Bypass Surgery on Intestinal Metabolism: Prospective, Longitudinal Mechanistic Clinical Trial |
| Q48250199 | The Long-Term Effects of Bariatric Surgery on Type 2 Diabetes Remission, Microvascular and Macrovascular Complications, and Mortality: a Systematic Review and Meta-Analysis. |
| Q38812536 | The Role of the Vagal Nucleus Tractus Solitarius in the Therapeutic Effects of Obesity Surgery and Other Interventional Therapies on Type 2 Diabetes. |
| Q47382190 | The Time to Weight-Loss Steady State After Gastric Bypass Predicts Weight-Loss Success |
| Q36226209 | The association between severity of King's Obesity Staging Criteria scores and treatment choice in patients with morbid obesity: a retrospective cohort study |
| Q97530631 | The association between socioeconomic factors and weight loss 5 years after gastric bypass surgery |
| Q38641840 | The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease |
| Q37074338 | The evolving role of bariatric surgery in patients with type 1 diabetes and obesity |
| Q35855101 | The gut microbiome, diet, and links to cardiometabolic and chronic disorders |
| Q30378189 | The impact of laparoscopic diverted sleeve gastrectomy with ileal transposition (DSIT) on short term diabetic medication costs |
| Q38733474 | The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions |
| Q35376124 | The long-term effects of bariatric surgery for type 2 diabetes: systematic review and meta-analysis of randomized and non-randomized evidence |
| Q41363406 | The role of bariatric surgery to treat diabetes: current challenges and perspectives |
| Q39093724 | The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: A multi-center study |
| Q97530675 | Therapeutic use of intermittent fasting and ketogenic diet as an alternative treatment for type 2 diabetes in a normal weight woman: a 14-month case study |
| Q99545621 | Type 2 diabetes and metabolic surgery guidelines and recommendations should urgently be unified |
| Q91917636 | Type 2 diabetes care: Improvement by standardization at a diabetes rehabilitation clinic. An observational report |
| Q35757175 | Type 2 diabetes mellitus and microvascular complications 1 year after Roux-en-Y gastric bypass: a case-control study |
| Q30276811 | Type 2 diabetes remission following gastric bypass: does diarem stand the test of time? |
| Q92088246 | Understanding the mechanisms of reversal of type 2 diabetes |
| Q39035697 | Vascular risk in obesity: Facts, misconceptions and the unknown |
| Q58692882 | Weight Loss Medications in Young Adults after Bariatric Surgery for Weight Regain or Inadequate Weight Loss: A Multi-Center Study |
| Q33601449 | Weight Loss and Heart Failure: A Nationwide Study of Gastric Bypass Surgery Versus Intensive Lifestyle Treatment |
| Q34503739 | Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action |
| Q47186948 | Weight and Metabolic Outcomes 12 Years after Gastric Bypass |
| Q38539937 | Weight loss interventions and progression of diabetic kidney disease |
| Q100636144 | Weight loss is the major player in bariatric surgery benefits |
| Q57108626 | Weight-Independent Mechanisms of Glucose Control After Roux-en-Y Gastric Bypass |
| Q88766740 | Why Weight? An Analytic Review of Obesity Management, Diabetes Prevention, and Cardiovascular Risk Reduction |
| Q89281042 | [Bariatric surgery: Expectations and therapeutic goals-a contradiction?] |
| Q52786916 | [Metabolic surgery or conservative measures as therapy of obese type 2 diabetics?] |
| Q89533416 | [Outcomes of bariatric surgery in adolescents as compared with adults : Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) vs. LABS] |
| Q85938480 | [Patient selection as the key to success of metabolic surgery] |
| Q50881791 | [The way from cost approval to bariatric surgery : Analysis of resource utilization in a maximum care hospital]. |
| Q57917235 | ‘Bariatric surgery for type 2 diabetes always produces a good outcome’ |
Search more.